Cargando…
SARS‐CoV‐2, COVID‐19, skin and immunology – What do we know so far?
The pandemic condition coronavirus disease (COVID‐19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), can take asymptomatic, mild, moderate, and severe courses. COVID‐19 affects primarily the respiratory airways leading to dry cough, fever, myalgia, headache, fatig...
Autores principales: | Novak, Natalijia, Peng, Wenming, Naegeli, Mirjam C., Galvan, Christina, Kolm‐Djamei, Isabel, Brüggen, Charlotte, Cabanillas, Beatriz, Schmid‐Grendelmeier, Peter, Catala, Alba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404682/ https://www.ncbi.nlm.nih.gov/pubmed/32658359 http://dx.doi.org/10.1111/all.14498 |
Ejemplares similares
-
What we know so far
Publicado: (2021) -
Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021) -
Autoimmune pancreatitis: What we know so far
por: Masood, Muaaz
Publicado: (2021) -
Incremental Hemodialysis: What We Know so Far
por: Soi, Vivek, et al.
Publicado: (2022) -
Monkeypox transmission—what we know so far
por: Venkatesan, Priya
Publicado: (2022)